Notably, NLGN3 is not the exclusive regulator of activity-dependent glioma growth, as NLGN3 deficiency only partially attenuates glioma cell mitogenic potential rather than completely abolishing it. This evidence concerns the gene NLGN3 and central nervous system cancer.